Normal weight obesity/Bibliography: Difference between revisions
imported>Sawdah Jakda No edit summary |
imported>Sawdah Jakda No edit summary |
||
| Line 3: | Line 3: | ||
[[User:Akiko Fukui|Akiko Fukui]] 14:21, 11 October 2011 (UTC) | [[User:Akiko Fukui|Akiko Fukui]] 14:21, 11 October 2011 (UTC) | ||
Ruderman NB, Schneider SH, Berchtold P, (1981) 'The "metabolically-obese," normal weight individual', The American Journal of Clinical Nutrition 34, 1617-1621: "these metabolically obese, normal- weight individuals... difficult to detect by any criteria. Suggested that..associated metabolic disorders such as hypertriglyceridemia and maturity onset diabetes would benefit from caloric restrictions." [[User:Catriona Thompson|Catriona Thompson]] 14:38, 11 October 2011 (UTC); [[User:Sawdah Jakda|Sawdah Jakda]] 22:41, 13 October 2011 (UTC) | Ruderman NB, Schneider SH, Berchtold P, (1981) '''The "metabolically-obese," normal weight individual''', The American Journal of Clinical Nutrition 34, 1617-1621: "these metabolically obese, normal- weight individuals... difficult to detect by any criteria. Suggested that..associated metabolic disorders such as hypertriglyceridemia and maturity onset diabetes would benefit from caloric restrictions." [[User:Catriona Thompson|Catriona Thompson]] 14:38, 11 October 2011 (UTC); [[User:Sawdah Jakda|Sawdah Jakda]] 22:41, 13 October 2011 (UTC) | ||
A Romero-Corral, VK Somers, J Sierra-Johnson, Y Korenfeld, S Boarin, J Korinek, MD Jensen, G Parati and F Lopez-Jimenez,(2010) 'Normal weight obesity: the risk factor for cardiometabolic dysregulation and cardiovascular mortality', European Heart Journal, Vol. 31; 737-746: | A Romero-Corral, VK Somers, J Sierra-Johnson, Y Korenfeld, S Boarin, J Korinek, MD Jensen, G Parati and F Lopez-Jimenez,(2010) '''Normal weight obesity: the risk factor for cardiometabolic dysregulation and cardiovascular mortality''', European Heart Journal, Vol. 31; 737-746: | ||
"the determination of adiposity by methods more accurate than BMI could have public health implications. Our study shows that NWO is significantly associated with cardiometabolic dysregulation and a high prevalence of metabolic syndrome... similar to the prevalence of metabolic syndrome described in overweight subjects." [[User:Sawdah Jakda|Sawdah Jakda]] 22:41, 13 October 2011 (UTC) | "the determination of adiposity by methods more accurate than BMI could have public health implications. Our study shows that NWO is significantly associated with cardiometabolic dysregulation and a high prevalence of metabolic syndrome... similar to the prevalence of metabolic syndrome described in overweight subjects." [[User:Sawdah Jakda|Sawdah Jakda]] 22:41, 13 October 2011 (UTC) | ||
RV Considine, MK Sinha, ML Heiman, A Kriauciunas, TW Stephens, MR Nyce, JP Ohannessian, CC Marco, LJ McKee, TL Bauer and JF Caro (1996), 'Serum immunoreactive- leptin concentrations in normal- weight and obese humans', The New England Journal of Medicine, Vol. 334 (5); 292-295: "We found that leptin... is detectable in serum and that obese subjects have higherserum leptin concentrations than normal- weight subjects. The values were most closely related with the percentage of body fat." [[User:Sawdah Jakda|Sawdah Jakda]] 22:41, 13 October 2011 (UTC) | RV Considine, MK Sinha, ML Heiman, A Kriauciunas, TW Stephens, MR Nyce, JP Ohannessian, CC Marco, LJ McKee, TL Bauer and JF Caro (1996), '''Serum immunoreactive- leptin concentrations in normal- weight and obese humans''', The New England Journal of Medicine, Vol. 334 (5); 292-295: "We found that leptin... is detectable in serum and that obese subjects have higherserum leptin concentrations than normal- weight subjects. The values were most closely related with the percentage of body fat." [[User:Sawdah Jakda|Sawdah Jakda]] 22:41, 13 October 2011 (UTC) | ||
Revision as of 17:45, 13 October 2011
- Please sort and annotate in a user-friendly manner. For formatting, consider using automated reference wikification.
A. de Lorenzo, V. del Gobbo, M. G. Premrov, M. Bigioni, F. Galvano, and L. Di Renzo, “Normal-weight obese syndrome: early inflammation?” The American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 40–45, 2007 Akiko Fukui 14:21, 11 October 2011 (UTC)
Ruderman NB, Schneider SH, Berchtold P, (1981) The "metabolically-obese," normal weight individual, The American Journal of Clinical Nutrition 34, 1617-1621: "these metabolically obese, normal- weight individuals... difficult to detect by any criteria. Suggested that..associated metabolic disorders such as hypertriglyceridemia and maturity onset diabetes would benefit from caloric restrictions." Catriona Thompson 14:38, 11 October 2011 (UTC); Sawdah Jakda 22:41, 13 October 2011 (UTC)
A Romero-Corral, VK Somers, J Sierra-Johnson, Y Korenfeld, S Boarin, J Korinek, MD Jensen, G Parati and F Lopez-Jimenez,(2010) Normal weight obesity: the risk factor for cardiometabolic dysregulation and cardiovascular mortality, European Heart Journal, Vol. 31; 737-746: "the determination of adiposity by methods more accurate than BMI could have public health implications. Our study shows that NWO is significantly associated with cardiometabolic dysregulation and a high prevalence of metabolic syndrome... similar to the prevalence of metabolic syndrome described in overweight subjects." Sawdah Jakda 22:41, 13 October 2011 (UTC)
RV Considine, MK Sinha, ML Heiman, A Kriauciunas, TW Stephens, MR Nyce, JP Ohannessian, CC Marco, LJ McKee, TL Bauer and JF Caro (1996), Serum immunoreactive- leptin concentrations in normal- weight and obese humans, The New England Journal of Medicine, Vol. 334 (5); 292-295: "We found that leptin... is detectable in serum and that obese subjects have higherserum leptin concentrations than normal- weight subjects. The values were most closely related with the percentage of body fat." Sawdah Jakda 22:41, 13 October 2011 (UTC)